ÂÜÀòÂÒÂ×

Wendy Yarno is currently a board member at IDEAYA Biosciences. Prior to this, they were with Global Blood Therapeutics, MyoKardia, Aratana Therapeutics Inc, and Medivation. Wendy has also served on the board of directors for ADial Pharmaceuticals, openQ, Alder Biopharmaceuticals Inc., and Durata Therapeutics. Durata Therapeutics was acquired in November 2014. Wendy has also worked with St. Jude Medical in the past.

Wendy Yarno's educational career includes an MBA from the Fox School of Business at Temple University, as well as a B.S. in Marketing from Portland State University - School of Business.